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Introduction
Hypertensive disorders complicate pregnancy and form
one aspect of the deadly triad, along with hemorrhage
and infection, and result in significant maternal mor-
bidity and mortality. Hypertension complicates 10% of
all pregnancies [1], and the only known cure or defini-
tive treatment is pregnancy termination. Despite wide-
spread research, the exact nature of the disease is not
fully understood. Its progression may be slow, rapid or
fulminant. Thus, for effective clinical management, it
should always be overdiagnosed in order to prevent
eclampsia [2].
A recent report suggested that no single test 
currently fulfils all the established criteria for a good
predictor of hypertensive disorders of pregnancy [3].
We, therefore, carried out a prospective study to assess
the values of 24-hour urinary protein and calcium
measurements in predicting preeclampsia.
Materials and Methods
The study group consisted of 200 pregnant women
(age, 18–35 years) attending the outpatient department
of the Post-Graduate Institute of Medical Sciences,
Rohtak. The women were enrolled at 20–28 weeks’
gestation and followed up until delivery. Women with
a history of hypertension, diabetes mellitus, renal dis-
ease, hemoglobin < 8 g/dL, multiple gestations or uri-
nary tract infection were excluded from the study.
Informed consent was obtained from all women.
Routine investigations, along with measurements
of blood pressure, weight, 24-hour urinary protein and
calcium, were performed at the time of registration.
Signs and symptoms of preeclampsia were clinically
evaluated at each follow-up visit.
Urinary protein was measured using the biuret
method, and calcium was measured using the ortho-
cresolphthalein complexone method. The records were
reviewed, and results were given as median and range.
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SUMMARY
Objective: To assess the efficacy of 24-hour urinary protein and calcium for the prediction of preeclampsia.
Materials and Methods: Two hundred normotensive women at 20–28 weeks’ gestation were enrolled in the study.
All women were asked to collect a 24-hour urine sample. Urinary protein and calcium were measured and
expressed as milligrams per 24 hours. Sensitivity, specificity and predictive values were calculated for each test,
and cutoff values were calculated using receiver operating characteristic curves.
Results: Twenty-one of the 200 women developed preeclampsia, including eight who developed severe pre-
eclampsia and 13 who developed mild preeclampsia. Compared with the normotensive women (n = 179), the
hypertensive patients (n = 21) had significantly lower urinary calcium excretion (167.23 ± 80.63 mg vs. 277.43 ±
60.38 mg) and higher proteinuria (351.14 ± 41.58 mg vs. 296.33 ± 30.03 mg).
Conclusion: A decrease in 24-hour urinary calcium and increase in protein between 20–28 weeks’ gestation are
risk factors for preeclampsia. [Taiwan J Obstet Gynecol 2009;48(2):113–115]
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The best cutoff point was established by analyzing the
receiver operating characteristic (ROC) curves. Sensi-
tivity, specificity, and positive and negative predictive
values were calculated.
Results
The present study population comprised 200 normo-
tensive, pregnant women (at 20–28 weeks’ gestation).
Twenty-one women (10.5%) who developed preeclamp-
sia were included in the study group, and those who
remained normotensive (89.5%) were used as controls.
There were no statistically significant differences in age
and parity between the two groups.
Of the patients who developed preeclampsia (n=21),
62% were primigravida, compared with only 54% of
the control group. The clinical and laboratory charac-
teristics of the subjects are shown in the Table. The
mean value of 24-hour urinary calcium in the hyperten-
sive group was 167.23 ± 80.63 mg (range, 80–340 mg),
and that of the control group was 277.43 ± 60.38 mg
(range, 126–392 mg). The mean value of 24-hour pro-
tein was 351.14 ± 41.58 mg (range, 200–450 mg) in
the hypertensive group and 296.33 ± 30.03 mg (range,
260–460 mg) in the control group. The 24-hour urinary
calcium was reduced (p < 0.01) and 24-hour urinary
protein was increased (p < 0.05) in those with pre-
eclampsia, compared with the control group. The best
cutoff point for identifying the risk of complications
was obtained by analyzing the ROC curves for 24-hour
urinary calcium and protein.
The ROC curves are shown in Figures 1 and 2. 
The diagnostic performance of the measurements was
expressed as areas under the curves, those of which for
calcium and protein were 0.854 and 0.846, respec-
tively. Sensitivity and specificity for the threshold of
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Figure 1. Receiver operating characteristic curve showing
24-hour urinary calcium.
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Figure 2. Receiver operating characteristic curve showing
24-hour urinary protein.
Table. Anthropometric, clinical and laboratory characteristics*
Normotensive group Hypertensive group
p
(n = 179) (n = 21)
Maternal age (yr) 23.13 ± 3.22 (19–35) 23.52 ± 3.66 (19–35) > 0.05
Gravidity 1.59 ± 0.87 (1–6) 1.7 ± 0.97 (1–5) > 0.05
Hemoglobin (g/dL) 9.2 ± 4.70 8.90 ± 5.21 > 0.05
Blood glucose (mg/dL) 79.22 ± 8.26 74.26 ± 9.21 > 0.05
Blood urea (mg/dL) 20.20 ± 4.29 21.71 ± 4.70 > 0.05
Serum creatinine (mg/dL) 0.82 ± 0.15 0.84 ± 0.13 > 0.05
Serum uric acid (mg/dL) 3.26 ± 1.2 5.76 ± 2.23 > 0.05
Mean arterial pressure (mmHg) 91.892 ± 6.17 104.88 ± 6.96 < 0.001
24-hour calciuria (mg/24 hour) 277.43 ± 60.38 (126–392) 167.23 ± 80.63 (80–340) < 0.001
24-hour proteinuria (mg/24 hour) 296.33 ± 30.03 (260–460) 351.14 ± 41.58 (260–450) < 0.05
*Data are presented as mean ± standard deviation, or mean ± standard deviation (range).
220 mg/24-hour urine for calcium were both 81%. The
positive and negative predictive values at this level
were 33% and 97%, respectively. Sensitivity and speci-
ficity for a threshold of 310 mg/24-hour urine for pro-
tein were 86% and 72%, respectively. The positive and
negative predictive values at this level were 26% and
98%, respectively.
Discussion
Preeclampsia is a pregnancy-specific, multisystem dis-
order characterized by the development of hyperten-
sion and proteinuria after 20 weeks’ gestation. Renal
excretion of calcium increases during normal pregnancy,
and hypercalciuria in normal pregnancy is a conse-
quence of an increased glomerular filtration rate [4,5].
Serum calcium levels in preeclampsia patients are sim-
ilar to those in normotensives, but some studies have
suggested that urinary calcium excretion is consider-
ably reduced [6–9]. Taufield et al [1] noted marked
hypocalciuria in patients with hypertensive disorders
of pregnancy. Sanchez-Ramos et al [4] reported that
excretion of calcium was reduced in the third trimester
in women with preeclampsia compared with normoten-
sive women. A study by Roelofsen et al [10] measured
urinary calcium excretion in normal and complicated
pregnancies, but failed to find hypocalciuria in pre-
eclamptic women.
Compared with normal pregnancies, preeclamptic
patients excrete significantly higher amounts of uri-
nary protein. The increased albumin excretion in these
patients appeared, on average, 9 weeks prior to the
development of hypertension [11–15].
In our study, we found that low urinary calcium and
higher urinary protein were risk factors for preeclamp-
sia in asymptomatic pregnant women, when the tests
were performed at 20–28 weeks’ gestation. Seventy-six
percent of our preeclamptic patients had hypocalciuria
and 81% had proteinuria, defined by the respective
cutoff points.
Measurement of 24-hour urinary calcium and pro-
tein excretion has advantages as a diagnostic test; it is
noninvasive, inexpensive, and easy to carry out. The use
of 24-hour urinary protein and calcium as early predic-
tors will help to identify pregnant females at high risk
of preeclampsia and prompt the initiation of education
and prophylactic interventions (i.e. primary preven-
tion, e.g. close prenatal care, calcium supplementation,
low-dose aspirin). These tests can also be used as selec-
tion criteria in research studies.
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